Glucagon-Like Peptide-1 (7-36) Amide as a Novel Neuropeptide Enrique Blâzquez

Molecular Neurobiology

Volumn 18, Issue 2, 1998, Pages 157-173

  Alvarez, Elvira ^a,b   Navarro, Miguel ^c   Roncero, Isabel ^b   Rodriguez Fonseca, Fernando ^a   Chowen, Julie A ^b   Zueco, José A ^c  

^a Facultad de Medicina   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Arterial blood pressure; Brain; Brain receptors; Central effects; Food intake; Gastric acid secretion; Glp 1 (7 36) amide; Neurotransmitter release; Thermor gulation; Water intake

Indexed keywords

EID: 0032431602     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Alvarez E., Roncero L, Chovven J. A., Thorens B., and Blâzquez E. (1996) Expression of the glucagon-like receptor gene in rat brain. J. Neurochem. 66,920-927.
2. Banting F. G. and Best C. H. (1922) The internal secretion of the pancreas. J. Lab. Clin. Mcd. 7, 251-266.
3. Barners S., Whistler H. Lv Hughes J., Woodruff G. N., and Hunter J. C. (1991) Effect of cholecystokinin octapeptide on endogenous amino acid release from the rat ventromedial nucleus of the hypothalamus and striatum. J. Nenrochem. 56, 1409-1416.
4. Barragân J. M., Rodriguez R., and Blâzquez E. (1994) Changes in arterial blood pressure and heart rate induced by glucagon-like peptide-1-(7-36) amide in rats. Am. J. Physiol. 266, E459-E466.
5. Barragân J. M., Rodriguez R., Eng J., and Blâzquez E. (1996) Interactions of exendin-(9-39) with the effects of glucagon-like peptide-l-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regitl Pept. 67,63-68.
6. Beak S. A., Small C. J., Ilovaiskaia I., Hurley J. C, Ghatei M. A., Bloom S. R., and Smith D. M. (1996) Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on cc-TSH cells. Endocrinology 137, 4130-4138.
7. Bell G. L, Santerre R. F., and Mullenbach G. T. (1983) Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302, 716-718.
8. Bullock B. P., Scottheller R., and Habener J. R (1996) Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137, 2968-2978.
9. Calvo J. C., Yusta B., Mora R, and Blâzquez E. (1995a) Structural characterization by affinity cross-linking of glucagon-like peptide-1 (7-36) amide receptor in rat brain. J. Nenrochem. 64, 299-306.
10. Calvo J. C., Gisolfi C. V., Blâzquez E., and Mora F. (1995b) Glucagon-like peptide-1 (7-36) amide induces the release of aspartic acid and glutamine by the ventromedial hypothalamus of the conscious rat. Brain Res. Bull. 38,435-439.
11. Campos R. V., Lee Y. C., and Drucker D. J. (1994) Divergent tissue-specific and developmental expression of receptors for glucagon and glucagon-like peptide-1 in the mouse. Endocrinology 134, 2156-2164.
12. Cechetto D. R (1987) Central representation of visceral function. Fed. P roc. 46,17-23.
13. Dillon J. S., Tanizawa Y., Wheeler M. B., Leng X. H., Ligon B. B., Rabin D. H., et al. (1993) Cloning and functional expression of the human glucagonlike peptide-1 (GLP-1) receptor. Endocrinology 133,1907-1910.
14. Drucker D. J. and Asa S. (1988) Glucagon gene expression in vertebrate brain. J. Biol. Client. 263, 13,475-13,478.
15. Drucker D. J., Philippe J., Mojsov S., Chick W. L., and Habener J. F. (1987) Glucagon-like peptide I stimulates insulin gene expression and increases
16. cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sei. USA 84,3434-3438.
17. Drucker D. J., Ehrlich P., Asa S. L., and Brubaker P. (1996) Induction of intestinal proliferation by glucagon-like peptide-2. Proc. Natl. Acad. Sei. USA 93,7911-7916.
18. Eng J., Kleiman W. A., Singh L., Singh G., and Raufman J. P. (1992) Isolation and characterization of exendin-4 and exendin-3 analogues from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J. Biol. Client. 267, 7402-7405.
19. Fürnsinn C. and Ebner K. W.W (1995) Failure of GLP-1 (7-36) amide to affect glycogenesis in rat skeletal muscle. Diabetologia 38,864-867.
20. Ghiglione M., Blâzquez E., Uttenthal L. O., de Diego J. G., Alvarez E., George S. K., et al., (1985) Glucagon-like peptide-1 does not have a role in hepatic carbohydrate metabolism. Diabetologia 28,920-921.
21. Goke R. and Conlon J. M. (1988) Receptors for glucagon-like peptide-1 (7-36) amide on rat insulinoma-derived cells. J. Endocrinol. 116, 357-362.
22. Göke R., Fehmann H. C., Linn T., Schmidt H., Krause M., Eng J., et al., (1993) Exendin-4 is a high potency agonist and truncated exendin-9 (9-39) amide an antagonist at the glucagon-like peptide-l-(7-36) amide receptor of insulin-secreting ß-cells. J. Biol. Chem. 268,19,650-19,655.
23. Göke R., Larsen P. J., Mikkelsen J. C., and Sheikb S. P. (1995a) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur. J. Neurose 7, 2294-2300.
24. Göke R., Larsen P. J., Mikkelsen J. C., and Sheikh S. P. (1995b) Identification of specific binding sites for glucagon-like peptide-1 on the posterior lobe of the rat pituitary. Neiiroendocrinology 62, 130-134.
25. Gutniak M., Orskov C., Holst J. J., Ähren B., and Efendic S. (1992) Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N. Engl. J. Med. 326,1316-1322.
26. Gutzwiller J. P., Göke B., Drewe J., Ketterer S., Handschin D., Hildebrand B., et al. (1997) Glucagon-like peptide-1 is a physiologie regulator of food intake in humans, in Invited Workshop: Glucagon-Like Peptide-1 (GLP-1) 7th Annual Meeting of European Neuropeptide Club. May 21-24, 1997, Marburg, Germany.
27. Heinrich G., Gross P., and Habener J. F. (1984) Glucagon gene sequence: four of six exons encode separate functional domains of rat preproglucagon. J. Biol Cliem. 259,14082-14087.
28. Herrmann C., Vöge A., and Göke B. (1993) Regulation of glucagon-like peptide (GLP-1) release from the isolated perfused rat ileum by nutrients, peptides and neuromediators. Digestion 54, 367.
29. Hertz L. and Schousboe A. (1986) Role of astrocytes in compartimentation of amino acids and energy metabolism, in: Biochemistry, Physiology and Pharmacology of Astrocytes (Fedoroff S. and Vernadakis A., eds), Academic, New York, p. 179.
30. Hoist J. J., and (Drskov C. (1994) Glucagon and other / .proglucagon-derived peptides, in Gut Peptides: Biochemistry and Physiology (Walsh J. H. and Dockray G. J., eds), Raven, New York, p. 305.
31. Hoosein N. M. and Gurd R. S. (1984) Human glucagon-like peptides 1 and 2 activate rat brain adenylate cyclase. FEBS Lett. 178,83-86.
32. Hupe-Sodmann K., MC Gregor G. P., Bridenbaug R., Göke R., Göke B., Thole H., et al. (1995) Characterisation of the processing by human neutral endopeptidase 24.11 of GLP-1 (7-36) amide and comparison of the substrate specificity of the enzyme for other glucagon-like peptides. Regul. Pept. 58,149-156.
33. Jetton T. L., Liang Y, Petepher C. C., Zimmerman E. C., Cox F. G., Horvath K., et al. (1994) Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut. J. Biol. Chem. 269,3641-3654.
34. Jin S. L. C., Han V. K. M., Simmons J. E., Towle A. C., Lander J. M., and Lund P. K. (1988) Distribution of glucagon-like peptide-1 (GLP-1), glucagon and glicentin in the rat brain: an immunocytochemical study. J. Comp. Neural. 271, 519-532.
35. Kanse S. M., Kreymann B., Ghatei M. A., and Bloom S. R. (1988) Identification and characterization of glucagon-like peptide-1 (7-36) amide binding sites in the rat brain and lung. FEBS Lett. 241, 209-212.
36. Kimball C. P. and Murlin J. R. (1923) Aqueous extracts of pancreas. III. Some precipitation reactions of insulin. J. Biol. Chem. 58,337-346.
37. Kreymann B., Williams G., Ghatei M. A., and Bloom S. R. (1987) Glucagon-like peptide-1 (7-36): a physiological incretin in man. Lancet 2,1300-1304.
38. Kreymann B., Ghatei M. A., Burnet P., Williams G., Kanse S., Diani A. R., et al. (1989) Characteriza-
39. tion of glucagon-like peptide-1 (7-36) amide in the hypothalamus. Brain Res. 502,325-331.
40. Lambert P. C, Wilding J. P. K, Ghatei M. A., and Bloom S. R. (1994) A role for GLP-1 (7-36) NH2 in the central control of feeding behavior. Digestion 54,360-361.
41. Layer P., Franke A., Hoist J. J., Grandt D., and Goebell H. (1996) Glucagon-like peptide-1 (GLP-1) inhibits pancreatic enzyme secretion in humans. Gastroenterology 110, F1409.
42. Mojsov S., Heinrich G., Wilson I. B., Ravazzola M., Orci L., and Habener J. F. (1986) Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-transcriptional processing. J. Biol. Cliem. 261,11880-11889.
43. Mojsov S., Weir G. C., and Habener J. F. (1987) Insulinotropin: glucagon-like peptide-1 (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J. Clin. Invest. 79, 616-619.
44. Mora F., Exposito I., Sanz B., and Blâzquez E. (1992) Selective release of glutamine and glutamic acid produced by perfusion of GLP-1 (7-36) amide in the basal ganglia of the conscious rat. Brain Res. Bull. 29,359-361.
45. Murphy S. and Pearce B. (1987) Functional receptors for neurotransmitters on astroglial cells. Neuwscience 22,381-394.
46. Navarro M., Rodriguez de Fonseca F., Zueco J. A., Gomez R., and Blâzquez E. (1994) Changes in food intake induced by GLP-1 (7-36) amide in the rat Abstract in 15th International Diabetes Federation Congress, Kobe, Japan.
47. Navarro M., Rodriguez de Fonseca F., Alvarez E., Chowen J. A., Zueco J. A., Gomez R., et al. (1996) Colocalization of glucagon-like peptide-1 (GLP1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: Evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake. J. Neiiwchem. 67,1982-1991.
48. Norenberg M. C. and Martfnez-Hernandez A. (1979) Fine structural localization of glutaminesynthethase in astrocytes of rat brain. Brain Res. 161,303-310.
49. Oomura Y, Sasaki K., Suzuki K., Muto T., Li A. J., Ogita Z., et al. (1992) A new brain glucosensor and its physiological significance. Am. J. Clin. Nutr. 55, 2785-2825.
50. (Drskov C., Rabenhoj L., Kofod H., Wettergren A., and Hoist J. J. (1994) Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 43,535-539.
51. Orskov C, Wettergren A., Poulsen S. C. S., and Hoist J. J. (1995) Is the effect of glucagon-like peptide-1 on gastric emptying centrally mediated. Diabetologia 38 (Suppl. 1), A39 (Abstract).
52. (Prskov C., Poulsen S. S., Moller M., and Holst J. J. (1996) Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accesible to circulating glucagon-like peptide I. Diabetes 45,832-835.
53. O'Shea D., Gunn I., Chen X., Bloom S., and Herbert J. (1996) A role for central glucagon-like peptide1 in temperature regulation. Neuroreport 7, 830-832.
54. Panksepp J., Bekkedal M. Y. U., and Walter M. (1996) Potent suppresive effects of the putative agent GLP-1 on social-emotional behaviors. Soc. . ' Neitrosci. Abstrat 22, p 16.
55. Parmley W. W., Click G., and Sonnenblick P. (1968) Cardiovascular effects of glucagon in man. N. Engl. J. Med. 279,12-17.
56. Raufman J. P., Singh L., and Eng J. (1992) Truncated glucagon like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. J. Biol Oiem. 267,21,432-21,437.
57. Richter G., Göke R., Göke B., and Arnold R. (1990) Dexamethasone pretreatment of rat insulinoma cells decreases binding of glucagon-like peptide1 (7-36) amide. J. Endocriiwl. 126,445-450.
58. Richter G., Göke G., Göke B., Schmidt H., and Arnold R. (1991) Characterization of glucagonlike peptide-1 (7-36) amide receptors of rat lung membranes by covalent cross-linking. FEBS Lett. 280,247-250.
59. Richter G., Feddersen O., Wagner U., Barth P, Göke R., and Göke B. (1993) GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am. J. Physiol. 265, L374-L381.
60. Ruiz-Grande, C., Pintado J., Alarcön C., Castilla C., and Valverde I. (1990) Renal catabolism of human glucagon-like peptides 1 and 2. Can. J. Physiol. Pharmncol. 68,1568-1573.
61. Schjoldager B. T. G., Mortensen P. E., Christiansen J., (Drskov C., and Hoist J. J. (1989) GLP-1 (glucagon-like peptide-1) and truncated GLP-1, fragments of human proglucagon, inhibit gastric acid secretion in man. Dig. Dis. Sei. 35, 703-708.
62. Shick R. R., Worm Walde T., Zimmerman J. P., Schusdziarra V., and Classen M. (1994) Glucagon-like peptide 1: a novel brain peptide involved in feeding regulation in: Obesity in Europe (Ditschuneit H., Gries F. A., Hanner H.,
63. Schusdziarra V., and Wechsler J. G., eds.), Libbey, London, 363-367.
64. Shima K., Suda T., Nishimoto K., and Yoshimoto S. (1990) Relationship between molecular structures of sugars and their ability to stimulate the release of glucagon-like peptide-1 (GLP-1) from canine ileal loops. Ada Endocrinol. 123,464-470.
65. Shimizu L, Hirota M., Obhoshi C, and Shima K. (1987) Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. Endocrinology 121,1076-1082.
66. Suda K., Takahashi H., Fukase N., Manaka H., Tomija M., and Sasaki H. (1989) Distribution of molecular forms of glucagon-like peptides in the dog. Life Sei. 45,1793-1798.
67. Sugiyama K., Manaka H., Kato T., Yamatani K., Tominaga M., and Sasaki H. (1994) Stimulation of truncated glucagon-like peptide-1 release from isolated perfused canine ileum by glucose absorption. Digestion 55, 24-28.
68. Tang-Christensen M., Larsen P. J., Göke R., FinkJensen A., Jessop D. S., Moller M., et al. (1996) Central administration of GLP-1 (7-36) amide inhibits food and water intake in rats. Am. J. Physiol. 271, R848-856.
69. Thiele T. E., Van Dijk G., Campfield A., Smith F. J., Burn P., Woods S. C., et al. (1997) Central infusion of GLP-1, but not leptin, produces conditioned taste aversion in rats. Am. J. Physiol. 272, R726-R730.
70. Thorens B. (1992) Expression cloning of the pancreatic ßcell receptor for the gluco-incretin hormone glucagon-like peptide-1. Proc. Natl. Acad. Sei. USA 89,8641-8645.
71. Thorens B., Ponet A., Bühler L., Deng S. P., Morel P., and Widmann C. (1993) Cloning and functional expression of the human islet GLP-1 receptor. Diabetes 42,1678-1682.
72. Treherme J. M. and Ashford M. L. J. (1992) Extracellular cations modulate the ATP senstivity of ATPK+ channels in rat ventromedial hypothalamic neurons. Proc. R. Soc. Land. Biol. Sei. 247,121-124.
73. Turton M. D., O'Shea D., Gunn I., Beale S. A., Eduards C. M. B., Meeran K., Choi S. J., Taylor G. M., Heath M. M., Lambert P. D., Wilding J. P. H., Smith D. M., Elatei M. A., Herbert J., and Bloom S. R. (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379, 69-72.
74. Uttenthal O. and Bldzquez E. (1990) Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands. FEBS Lett. 262,139-141.
75. Uttenthal O., Toledano A., and Blâzquez E. (1992) Autoradiographic localization of receptors from glucagon-like peptide-1 (7-36) amide in rat brain. Neitropcptides 21,143-146.
76. Valverde I., Morales M., Clémente F., Lopez-Delgado M., Delgado E., Perea A., and VillanuevaPenacarrillo M. (1994) Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett. 283, 7-10.
77. Valverde I., Mérida E., Delgado E., Trapote M. A., and Villanueva-Penacarrillo M. L. (1993) Presence and characterization of glucagon-like peptide-1 (7-36) amide receptors in solubilized membranes of rat adipose tissue. Endocrinology 132, 75-79.
78. Van Dijk G., Thiele T. E., Seeley R. J., Woods S. C, and Bernstein J. L. (1997) Glucagon-like peptide1 and satiety. Nature 385,214.
79. Villanueva-Penacarrillo M. L., Alcântara A. L, Trapote M. A., Clémente F., Delgado E., and Valverde I. (1994) Potent glycogenic effect of GLP-1 (7-36) amide in rat skeletal muscle. Diabetologia 37,1163-1166.
80. Wang T., Edwards G. L., and Baue C. A. (1996) Glucagon-like peptide-1 (7-36) amide (GLP-1) activates the hypothalamic-pituitary-adrenal (HPA) axis of rats. Soc. Nciiwsd. Abstracts 22,456.
81. Wei Y., and Mojsov S. (1995) Tissue-specific expression of the human receptor for glucagon-like peptide-1: brain, heart and pancreatic forma have the same deduced amino acid sequences. FEES Lett. 358,219-224.
82. Wettergren A., Schjoldager B., Mortensen P. E., Myhre J., Christiansen J. and Hoist J. J. (1993) Truncated GLP-1 (proglucagon 72-107 amide) inhibits gastric and pancreatic functions in man. Dig. Dis. Sei. 38, 665-673.
83. Zullo J. A., Esquifino A. J., Chowder J. A., Alvarez E., Castrillion P. O., and Blâzquez E. (1999) Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAs in neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1 (7-36) amide on vasopressin and oxytocin release. J. Neiirochem., in press.